MENU
APR 27, 2022 9:00 AM PDT

Tale of amyloid filaments in neurodegenerative diseases

Speakers

Abstract
Date:  April 27, 2022
Time: 9:00am (PDT),  12:00pm (EDT), 6:00pm (CEST)
 
Abnormal accumulation of misfolded tau protein in filaments characterizes more than 20 neurodegenerative diseases—collectively called tauopathies. Most of these diseases can be attributed to mutations in tau gene. Cryo-electron microscopy (cryo-EM) has been used to solve the structures of tau filaments extracted from diseased brain tissue of neuropathologically confirmed cases of Alzheimer's disease, primary age-related tauopathy (PART), chronic traumatic encephalopathy (CTE), Pick's disease, and corticobasal degeneration (CBD). This study led to over 40 high resolution structures of tau filaments found in all these different tauopathies. On top of the previously studied diseases, we have also determined the structures of tau filaments from a further eight tauopathies including progressive supranuclear palsy (PSP) and argyrophilic grain disease (AGD). These cryo-EM findings suggest a hierarchical classification of tauopathies on the basis of their filament folds, which complements clinical diagnosis and neuropathology and also allows the identification of new tauopathies.
Different diseases are distinguished by different tau folds. To understand the relevance of these folds we require better model systems which can recapitulate this in vitro. This study led to the high-resolution structure determination 76 structures of recombinant tau filaments assembled in vitro, providing a new database for the greater amyloid field. Understanding their molecular mechanism holds important implications for future diagnostic and treatment approaches.
 
 
Learning Objectives
  • Review amyloid filaments and neurodegenerative diseases
  • Define what are taupathies and how are they related to neurodegenerative diseases
  • Describe how high throughput cryo-EM can help identify new tauopathies
  • Relate future opportunities and how these structures can be used for Pharma intervention
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
Loading Comments...
Show Resources